Azacitidine and pancytopenia Patient Reports February 11, 2012
Azacitidine Side Effects Report #4950113-0
Azacitidine side effect was reported by a Physician from UNITED KINGDOM on Mar 01, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: clostridium colitis, confusional state, faecal incontinence, lethargy, lower respiratory tract infection, neutropenic sepsis, pancytopenia, virus stool test positive. Azacitidine dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LOPERAMIDE, VALACYCLOVIR, PROBAC, BIOMAGNESIUM, ACETAMINOPHEN, TELMISARTAN, RIFAMPICIN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Azacitidine Side Effects Report #5006543-4
Azacitidine side effect was reported by a Physician from AUSTRALIA on May 02, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, confusional state, dehydration, haemorrhoidal haemorrhage, lethargy, lower respiratory tract infection, neutropenic sepsis, pancytopenia. Azacitidine dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LOPERAMIDE, VALACYCLOVIR, PROBAC, BIOMAGNESIUM, ACETAMINOPHEN, TELMISARTAN, RIFAMPICIN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Azacitidine Side Effects Report #5385471-9
Azacitidine side effect was reported by a Pharmacist from UNITED STATES on July 06, 2007. Male patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: febrile neutropenia, pancytopenia. Azacitidine dosage: 100MG EVERY DAY SQ. Patient was hospitalized. Patient recovered.
Azacitidine Side Effects Report #5574675-8
Azacitidine side effect was reported by a Pharmacist from UNITED STATES on Dec 26, 2007. Male patient, 69 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: pancytopenia. Azacitidine dosage: 140MG UD IV. Patient was hospitalized. Patient recovered.
Azacitidine Side Effects Report #4766521-7
Azacitidine side effect was reported by a Physician from UNITED KINGDOM on Aug 26, 2005. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: pancytopenia, urinary retention. Azacitidine dosage: 75 MG/M2 (165 MG, DAILY X 7. During the same period patient was treated with NIFEDIPINE, BENDROFLUAZIDE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Azacitidine Side Effects Report #4900803-0
Azacitidine side effect was reported by a Physician from UNITED KINGDOM on Jan 17, 2006. Male patient, 68 years of age, weighting 202.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, pancytopenia. Azacitidine dosage: 75 MG/M2 (165 MG, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with NIFEDIPINE, BENDROFLUAZIDE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Azacitidine Side Effects Report #6010858-0
Azacitidine side effect was reported by a Physician from UNITED STATES on Dec 08, 2008. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, pancytopenia, respiratory failure. Azacitidine dosage: unknown. Patient died.
Azacitidine and pancytopenia 